KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission. (Antimicrobial agents and chemotherapy, 2014)

(untitled) - Kuhen, K; Chatterjee, A; Rottmann, M; Gagaring, K; Borboa, R; Buenviaje, J; Chen, Z; Francek, C; Wu, T; Nagle, A; Barnes, S; Plouffe, D; et al.